Address
New Leaf Venture Partners
7 Times Square
Suite 3502, Times Square Tower
New York, NY 10036
United States
Phone
Email
Website
Recent investment activity
KANDO id: 3055
Funding rounds
Investment activity status
Active investor
Selected investments
Displaying 26 - 50 of 53| Company | Profile | Country | Date | Funding | ||
|---|---|---|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Transcept Pharmaceuticals Inc | Series D | ||||
|
|
Transcept Pharmaceuticals Inc | Series C | ||||
|
|
VaxInnate Corp | N/A | ||||
|
|
VaxInnate Inc | A biotechnology company, engages in the development and production of vaccines for pandemic and seasonal influenza diseases. | Series C | |||
|
|
World Heart Corp | Medical device company developing implantable mechanical circulatory support systems for long-term use. | N/A | |||
|
|
AccessClosure Inc (Access Closure) | N/A | ||||
|
|
Afferent Pharmaceuticals Inc | N/A | ||||
|
|
Altura Medical Inc | Series A | ||||
|
|
Array BioPharma Inc | N/A | ||||
|
|
Artisan Pharma Inc | Provides critical-care and hospital-based therapeutics to patients, treating physicians, and payors in the United States and internationally. | Series A | |||
|
|
Artisan Pharma Inc | Provides critical-care and hospital-based therapeutics to patients, treating physicians, and payors in the United States and internationally. | Series C | |||
|
|
BioRelix Inc | Advanced fight against drug resistant microbes by attacking novel targets with novel drugs. | N/A Follow-on investment | |||
|
|
BioRelix Inc | Advanced fight against drug resistant microbes by attacking novel targets with novel drugs. | Series A Initial investment | |||
|
|
Concert Pharmaceuticals Inc | A biotechnology company creating new medicines through a novel scientific approach utilizing the naturally-occurring element deuterium. | Series C | |||
|
|
Concert Pharmaceuticals Inc | A biotechnology company creating new medicines through a novel scientific approach utilizing the naturally-occurring element deuterium. | Series B | |||
|
|
Direct Flow Medical Inc | Medical device developer | Series C Follow-on investment | |||
|
|
Direct Flow Medical Inc | Medical device developer | Series B | |||
|
|
GluMetrics Inc | Series C | ||||
|
|
IlluminOss Medical Inc | A privately held medical device company dedicated to the development of minimally invasive orthopedic systems. | Series C | |||
|
|
Oxford Immunotec Ltd | Venture | ||||
|
|
Oxford Immunotec Ltd | Series D | ||||
|
|
Reshape Medical Inc | Series C Initial investment | ||||
|
|
Reshape Medical Inc | Series B Initial investment | ||||
|
|
Reshape Medical Inc | Series A | ||||
|
|
Spine Wave Inc | Medical device company focused on degenerative disc disease, vertebral compression fractures, and nucleus replacement. | Series E |